STOCK TITAN

RadNet Names Four Leaders to Expanded Executive Roles

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

RadNet (NASDAQ: RDNT) announced the promotion of four senior leaders to expanded executive roles effective January 7, 2026. The changes elevate Stephen Forthuber to President & CEO, Eastern Operations, Norman Hames to President & CEO, Western Operations, Mital Patel to Executive VP & Chief Operating Officer, and Greg Sorensen, M.D., from Chief Science Officer to Chief Strategy Officer while remaining on RadNet’s board.

Company commentary ties the moves to recent record performance across Imaging Center and Digital Health segments and to a strategic focus on moving healthcare toward proactive disease prevention.

Loading...
Loading translation...

Positive

  • Four executives promoted effective Jan 7, 2026
  • Geographic leadership strengthened for Eastern and Western operations
  • Chief Strategy Officer role added while Dr Sorensen stays on board

Negative

  • No quantified near-term financial impact or guidance included in announcement

News Market Reaction 1 Alert

+0.06% News Effect

On the day this news was published, RDNT gained 0.06%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Leaders promoted 4 executives Expanded executive roles across operations, finance and strategy

Market Reality Check

$78.20 Last Close
Volume Volume 949,287 vs 20-day average 1,030,105 (relative volume 0.92), showing typical trading activity. normal
Technical Price $77.36 trading above 200-day MA at $65.38, indicating a pre-existing upward trend before this leadership news.

Peers on Argus

RDNT gained 4.3% with several diagnostics peers also positive today (e.g., GH +10.21%, CRL +3.72%, RVTY +3.7%, WGS +3.93%, SHC +2.35%). Scanner data, however, did not flag a sector-wide momentum move.

Historical Context

Date Event Sentiment Move Catalyst
Dec 01 AI product launch Positive -3.4% Launch of DeepHealth Breast Suite AI platform for breast cancer screening.
Nov 20 Commercial contract win Positive -1.3% Wichita Radiological Group adopts DeepHealth Operations Suite in five-year deal.
Nov 17 Clinical AI validation Positive +2.8% Nature Health study shows higher cancer detection with AI breast workflow.
Nov 12 Strategic collaboration Positive -1.3% Expanded GE HealthCare partnership to broaden AI-powered imaging solutions.
Nov 11 Acquisition Positive -2.9% Acquisition of CIMAR UK to advance AI-enabled imaging and screening in Europe.
Pattern Detected

Recent positive strategic and AI-related announcements have often been followed by mixed to negative next-day price reactions.

Recent Company History

Over the last few months, RadNet has emphasized AI-enabled imaging growth and strategic expansion. Key updates included AI breast cancer detection gains across >579,000 women, a Nature Health study validating enhanced detection, a broader GE HealthCare collaboration, and the CIMAR UK acquisition to extend digital reach in Europe. Commercially, DeepHealth signed Wichita Radiological Group to its Operations Suite under a five-year agreement. Despite generally positive strategic tone, four of the last five news events saw negative 24-hour price reactions, providing context for how leadership changes fit into an already active growth narrative.

Market Pulse Summary

This announcement highlights a deep bench of long-tenured leaders taking on broader roles across RadNet’s Eastern and Western operations, corporate operations and strategy. It follows a series of AI, acquisition and partnership milestones, indicating continued emphasis on growth and digital health. Investors may watch how these role changes support integration of prior deals, execution in both Imaging Center and Digital Health segments, and maintenance of record financial performance referenced by management in recent quarters.

AI-generated analysis. Not financial advice.

Bench of veteran leaders elevated to drive RadNet’s continued growth and innovation

LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a premier global developer of digital health solutions, announced today the promotion of four senior leaders to expanded executive roles in recognition of their decades of operational excellence and strategic growth.

Effective immediately, the executive leadership changes include:

  • Stephen Forthuber, President and Chief Operating Officer, Eastern Operations, to President and Chief Executive Officer, Eastern Operations.
  • Norman Hames, President and Chief Operating Officer, Western Operations, to President and Chief Executive Officer, Western Operations.
  • Mital Patel, Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer, to Executive Vice President and Chief Operating Officer.
  • Greg Sorensen, M.D., Chief Science Officer to Chief Strategy Officer. Dr. Sorensen will continue to serve as a member of RadNet’s Board of Directors.

“RadNet has achieved industry-leading growth, including record financial performance across both our Imaging Center and Digital Health segments in recent quarters. So much of our success results from the vision and dedication of this group of exceptional leaders, who reflect the strength and depth of our management team,” said Dr. Howard Berger, President and Chief Executive Officer, RadNet. "As we look ahead, we are boldly working to shape a future where healthcare moves from reactive detection toward proactive disease prevention. These leadership transitions position us well to continue our strong growth journey, while remaining focused on what matters most: delivering accessible, high-quality, patient-centered care."

About RadNet, Inc.
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 407 owned and/or operated outpatient imaging centers. RadNet’s markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. radnet.com

Jane Mazur
SVP, Corporate Communications
RadNet
+1 585-355-5978
jane.mazur@radnet.com

Mark Stolper
Executive Vice President and Chief Financial Officer
RadNet
+1 310-445-2800


FAQ

Who did RadNet (RDNT) promote on January 7, 2026?

RadNet promoted Stephen Forthuber, Norman Hames, Mital Patel, and Greg Sorensen to expanded executive roles effective Jan 7, 2026.

What new role does Greg Sorensen, M.D. hold at RadNet (RDNT)?

Greg Sorensen was named Chief Strategy Officer and will continue serving on RadNet’s board.

What operational changes did RadNet (RDNT) announce for Eastern and Western operations?

Stephen Forthuber becomes President & CEO, Eastern Operations and Norman Hames becomes President & CEO, Western Operations.

Did RadNet (RDNT) provide financial guidance tied to the January 7, 2026 promotions?

No; the announcement highlights recent record performance but does not provide new financial guidance or quantified impact.

How do RadNet’s leadership changes relate to its digital health strategy (RDNT)?

The company framed the promotions as supporting growth across Imaging Center and Digital Health segments and a shift toward proactive disease prevention.
Radnet

NASDAQ:RDNT

RDNT Rankings

RDNT Latest News

RDNT Latest SEC Filings

RDNT Stock Data

6.04B
67.21M
12.73%
94.2%
7.83%
Diagnostics & Research
Services-medical Laboratories
Link
United States
LOS ANGELES